|
|
|
| Master. Fill. Finish. | As the final step before products reach patients, fill and finish are critical to drug development. On top of quality standards, diverse manufacturing requirements, and the evolving regulatory landscape, the industry is experiencing pressure from the growth of low-volume therapeutics and multi-product facilities – resulting in rising needs for flexible manufacturing. Take control of your final formulation/filling by choosing a supplier who combines flexible single-use technologies, trusted regulatory expertise, and industry-leading support. |
|
|
FOCUS ON DOWNSTREAM MANUFACTURING |
|
|
|
By Chelsey Mattison, Novartis | Microfluidic platforms, such as labchip, are widely used for assessing wild type capsids. Now, engineered capsids are challenging these established workflows. | |
|
|
|
|
| Introduction To mRNA Manufacturing | Article | Cytiva | The SARS-CoV-2 virus has changed the course of scientific research around mRNA. Learn about mRNA manufacturing, the structure of a mRNA molecule, RNase-free considerations, and more. |
|
|
| Shedding Light On Oligonucleotide Manufacturing | Article | By Steve Foy, Asahi Kasei Bioprocess | While oligonucleotide therapeutics show promise by targeting genetic codes, scaling up manufacturing presents unique challenges requiring innovative equipment solutions to meet growing demand. |
|
|
DOWNSTREAM MANUFACTURING SOLUTIONS |
|
|
|
|
|
|
|
| The Case For Modernizing Small-Volume Aseptic Processing | White Paper | By Nik Ekman, application development manager, cell & gene therapy, CPC | Tube welding and biosafety cabinets present significant costs and risks for small-volume aseptic processing. Modern single-use aseptic connectors offer a more efficient alternative. |
|
|
|
|
|
| Connect With Bioprocess Online: |
|
|
|
